Table 3 Treatments given and complications that developed during the stays of patients admitted to adult intensive care units at selected public hospitals in Addis Ababa from January 1, 2022, to December 31, 2022 (nā€‰=ā€‰409).

From: Outcomes and factors associated with prolonged stays among patients admitted to adult intensive care unit in a resource-limited setting: a multicenter chart review

Variables

Categories

ICU Length of stay

Total

ā€‰<ā€‰14Ā days

ā€‰ā‰„ā€‰14Ā days

H2 blockers/proton pump inhibitors

Yes

269 (65.8%)

66 (16.1%)

335 (81.9%)

No

71 (17.4%)

3 (0.7%)

74 (18.1%)

Thrombolytics/anticoagulants

Yes

62 (15.2%)

167 (40.8%)

229 (56.0%)

No

7 (1.7%)

173 (42.3%)

180 (44.0%)

Sedatives/hypnotics

Yes

59 (14.4%)

35 (8.6%)

94 (23.0%)

No

281 (68.7%)

34 (8.3%)

315 (77.0%)

Vasopressors/inotropes

Yes

70 (17.1%)

11 (2.7%)

81 (19.8%)

No

270 (66.0%)

58 (14.2%)

328 (80.2%)

Infusion dose of vasopressors/inotropes (mcg/kg/min)

Minimal support (0.01ā€“0.05)

8 (9.9%)

2 (2.5%)

10 (12.3%)

Moderate support (0.05ā€“0.5)

37 (45.7%)

4 (4.9%)

41 (50.6%)

Maximal support (>ā€‰0.5)

25 (30.9%)

5 (6.2%)

30 (37.0%)

Blood product transfusion

Yes

56 (13.7%)

15 (3.7%)

71 (17.4%)

No

284 (69.4%)

54 (13.2%)

338 (82.6%)

Types of blood product

Whole blood

8 (11.3%)

6 (8.5%)

14 (19.7%)

Packed red blood cell

41 (57.7%)

12 (16.9%)

53 (74.6%)

Platelet

41 (57.7%)

12 (16.9%)

53 (74.6%)

Fresh frozen plasma

14 (19.7%)

3 (4.2%)

17 (23.9%)

Mechanical ventilation

Yes

125 (30.6%)

57 (13.9%)

182 (44.5%)

No

215 (52.6%)

12 (2.9%)

227 (55.5%)

Types mechanical ventilation

Invasive

120 (65.9%)

56 (30.8%)

176 (96.7%)

Noninvasive

5 (2.7%)

1 (0.5%)

6 (3.3%)

Length of stay on mechanical ventilation (days)

ā€‰<ā€‰7

100 (55.2%)

6 (3.3%)

106 (58.6%)

7ā€“14

22 (12.2%)

14 (7.7%)

36 (19.9%)

15ā€“21

0 (0.0%)

12 (6.6%)

12 (6.6%)

ā€‰>ā€‰21

3 (1.7%)

24 (13.3%)

27 (14.9%)

Tracheostomy

Yes

11 (2.7%)

23 (5.6%)

34 (8.3%)

No

329 (80.4%)

46 (11.2%)

375 (91.7%)

Complication

Yes

56 (13.7%)

51 (12.5%)

107 (26.2%)

No

284 (69.4%)

18 (4.4%)

302 (73.8%)

Types complication

Hospital acquired infections

17 (16.3%)

20 (19.2%)

37 (35.6%)

Acute kidney injury

19 (18.3%)

12 (11.5%)

31 (29.8%)

Pressure sore

6 (5.8%)

24 (23.1%)

30 (28.8%)

Electrolyte abnormality

18 (17.3%)

8 (7.7%)

26 (25.0%)

Ventilator associated pneumonia

3 (2.9%)

15 (14.4%)

18 (17.3%)

Hypoalbuminemia

6 (5.8%)

12 (11.5%)

18 (17.3%)

Upper gastrointestinal bleeding

10 (9.6%)

6 (5.8%)

16 (15.4%)

Othersa

12 (11.5%)

17 (16.3%)

29 (27.9%)

  1. aAnemia, catheter-associated urinary infection, deep vein thrombosis, drug induced liver injury, pulmonary embolism, tension pneumothorax, thrombocytopenia, thrombophlebitis.
Back to article page